Biosynthesis of ergothioneine: current state, achievements, and perspectives
Applied Microbiology and Biotechnology · 12.04.2025 · 109 (1)
DOI: 10.1007/s00253-025-13476-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 12.04.2025. Verfasst von Shun Sato und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Sustainable Chemistry, National Institute of Advanced Industrial Science and Technology (AIST), Central 5, 1-1-1 Higashi, Tsuk…. Hauptthemen laut MEDLINE: Ergothioneine, Bacteria. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ergothioneine (EGT) is a derivative of the amino acid L-histidine that is well known for its strong antioxidant properties. Recent studies on the functional characterization of EGT in both in vivo and in vitro systems have demonstrated its potential applications in pharmaceuticals, food, and cosmetics. The growing demand for EGT in novel applications necessitates the development of safe and cost-effective mass production technologies. Consequently, microbial fermentation for EGT biosynthesis has attracted significant attention. This review focuses on the biosynthesis of EGT via microbial fermentation, explores its biosynthetic mechanisms, and summarizes the latest advancements for industrial EGT production using engineered microbial strains. Key points • Ergothioneine (EGT) is an L-histidine derivative with strong antioxidant property. • Recent studies have revealed certain groups of microbes produce EGT naturally. • Superior EGT producers by genetic modification have been created.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute for Sustainable Chemistry, National Institute of Advanced Industrial Science and Technology (AIST), Central 5, 1-1-1 Higashi, Tsukuba, Ibaraki, 305-8565, Japan.
- New Business Division, Kureha Corporation, 3-3-2 Nihonbashi-Hamacho, Chuo-ku, Tokyo, 103-8552, Japan.
- Research Institute for Sustainable Chemistry, National Institute of Advanced Industrial Science and Technology (AIST), Central 5, 1-1-1 Higashi, Tsukuba, Ibaraki, 305-8565, Japan. morita-tomotake@aist.go.jp.
Zitieren
APA
Sato, S., Saika, A., Koshiyama, T., Higashiyama, Y., Fukuoka, T., & Morita, T. (2025). Biosynthesis of ergothioneine: current state, achievements, and perspectives. Applied Microbiology and Biotechnology, 109(1). https://doi.org/10.1007/s00253-025-13476-4
Vancouver
Sato S, Saika A, Koshiyama T, Higashiyama Y, Fukuoka T, Morita T. Biosynthesis of ergothioneine: current state, achievements, and perspectives. Applied Microbiology and Biotechnology. 2025;109(1). doi:10.1007/s00253-025-13476-4
BibTeX
@article{Sato2025,
author = {Sato, Shun and Saika, Azusa and Koshiyama, Tatsuyuki and Higashiyama, Yukihiro and Fukuoka, Tokuma and Morita, Tomotake},
title = {Biosynthesis of ergothioneine: current state, achievements, and perspectives},
journal = {Applied Microbiology and Biotechnology},
year = {2025},
volume = {109},
number = {1},
doi = {10.1007/s00253-025-13476-4}
}
EUVIMED